Characterization of the colorectal cancer-associated enhancer MYC-335 at 8q24: The role of rs67491583

Cancer Genetics

Volumn 205, Issue 1-2, 2012, Pages 25-33

  Tuupanen, Sari ^a   Yan, Jian ^b,d   Turunen, Mikko ^b   Gylfe, Alexandra E ^a   Kaasinen, Eevi ^a   Li, Li ^c   Eng, Charis ^c,d,e   Culver, Daniel A ^d   Kalady, Matthew F ^d,e   Pennison, Michael J ^f   Pasche, Boris ^f   Manne, Upender ^g   de la Chapelle, Albert ^h   Hampel, Heather ^h   Henderson, Brian E ⁱ   Le Marchand, Loic ^j   Hautaniemi, Sampsa ^a   Askhtorab, Hassan ^k   Smoot, Duane ^f,k   Sandler, Robert S ^l   Keku, Temitope ^l   Kupfer, Sonia S ^m   Ellis, Nathan A ^m   Haiman, Christopher A ⁱ   Taipale, Jussi ^b,n   Aaltonen, Lauri A ^a   more..

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e TAUSSIG CANCER INSTITUTE   (United States)

^f and Clinical Center   (United States)

^g UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^h OHIO STATE UNIVERSITY   (United States)

ⁱ UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^j UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^k HOWARD UNIVERSITY CANCER CENTER   (United States)

^l UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^m UNIVERSITY OF CHICAGO   (United States)

ⁿ KAROLINSKA INSTITUTE   (Sweden)

more..

Author keywords

Association; Colorectal cancer; Enhancer; Susceptibility variant; Transcription factor

Indexed keywords

ALLELE; ARTICLE; BINDING SITE; CHROMOSOME 8Q; CHROMOSOME VARIANT; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; ENHANCER REGION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC ENHANCEMENT; GENETIC RISK; GENETIC VARIABILITY; HUMAN; ONCOGENE MYC; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEQUENCE ANALYSIS; TRANSCRIPTION REGULATION;

ADULT; AFRICAN AMERICANS; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 8; COHORT STUDIES; COLORECTAL NEOPLASMS; ENHANCER ELEMENTS, GENETIC; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE FREQUENCY; GENES, MYC; GENOTYPE; HEK293 CELLS; HELA CELLS; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 84860235587     PISSN: 22107762     EISSN: 22107770     Source Type: Journal    
DOI: 10.1016/j.cancergen.2012.01.005     Document Type: Article

References (38)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2009. CA Cancer J Clin 2009, 59:225-249.
2. Agrawal S., Bhupinderjit A., Bhutani M.S., et al. Colorectal cancer in African Americans. Am J Gastroenterol 2005, 100:515-523. discussion 514.
3. Lichtenstein P., Holm N.V., Verkasalo P.K., et al. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000, 343:78-85.
4. Tomlinson I., Webb E., Carvajal-Carmona L., et al. A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. Nat Genet 2007, 39:984-988.
5. Broderick P., Carvajal-Carmona L., Pittman A.M., et al. A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk. Nat Genet 2007, 39:1315-1317.
6. Jaeger E., Webb E., Howarth K., et al. Common genetic variants at the CRAC1 (HMPS) locus on chromosome 15q13.3 influence colorectal cancer risk. Nat Genet 2008, 40:26-28.
7. Tomlinson I.P., Webb E., Carvajal-Carmona L., et al. A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3. Nat Genet 2008, 40:623-630.
8. Houlston R.S., Webb E., Broderick P., et al. Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer. Nat Genet 2008, 40:1426-1435.
9. Houlston R.S., Cheadle J., Dobbins S.E., et al. Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33. Nat Genet 2010, 42:973-977.
10. Tomlinson I.P., Carvajal-Carmona L.G., Dobbins S.E., et al. Multiple common susceptibility variants near BMP pathway loci GREM1, BMP4, and BMP2 explain part of the missing heritability of colorectal cancer. PLoS Genet 2011, 7:e1002105.
11. Yeager M., Orr N., Hayes R.B., et al. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet 2007, 39:645-649.
12. Easton D.F., Pooley K.A., Dunning A.M., et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 2007, 447:1087-1093.
13. Kiemeney L.A., Thorlacius S., Sulem P., et al. Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nat Genet 2008, 40:1307-1312.
14. Crowther-Swanepoel D, Broderick P, Di Bernardo MC, et al. Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk. Nat Genet;42:132-136.
15. Tuupanen S., Turunen M., Lehtonen R., et al. The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling. Nat Genet 2009, 41:885-890.
16. Pomerantz M.M., Ahmadiyeh N., Jia L., et al. The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer. Nat Genet 2009, 41:882-884.
17. Pittman A.M., Naranjo S., Webb E., et al. The colorectal cancer risk at 18q21 is caused by a novel variant altering SMAD7 expression. Genome Res 2009, 19:987-993.
18. Pittman A.M., Naranjo S., Jalava S.E., et al. Allelic variation at the 8q23.3 colorectal cancer risk locus functions as a cis-acting regulator of EIF3H. PLoS Genet 2010, 16. 6(9). pii: e1001126.
19. Carvajal-Carmona L.G., Cazier J.B., Jones A.M., et al. Fine-mapping of colorectal cancer susceptibility loci at 8q23.3, 16q22.1 and 19q13.11: refinement of association signals and use of in silico analysis to suggest functional variation and unexpected candidate target genes. Hum Mol Genet 2011, 20:2879-2888.
20. Launonen V., Avizienyte E., Loukola A., et al. No evidence of Peutz-Jeghers syndrome gene LKB1 involvement in left-sided colorectal carcinomas. Cancer Res 2000, 60:546-548.
21. Turunen M.M., Dunlop T.W., Carlberg C., et al. Selective use of multiple vitamin D response elements underlies the 1 alpha,25-dihydroxyvitamin D3-mediated negative regulation of the human CYP27B1 gene. Nucleic Acids Res 2007, 35:2734-2747.
22. McGill R., Tukey J.W., Larsen W.A. Variations of box plots. The American Statistician 1978, 32:12-16.
23. Huang R.S., Duan S., Shukla S.J., et al. Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a genomewide approach. Am J Hum Genet 2007, 81:427-437.
24. Dai M., Wang P., Boyd A.D., et al. Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res 2005, 33:e175.
25. Zweidler-Mckay P.A., Grimes H.L., Flubacher M.M., et al. Gfi-1 encodes a nuclear zinc finger protein that binds DNA and functions as a transcriptional repressor. Mol Cell Biol 1996, 16:4024-4034.
26. Heintzman N.D., Stuart R.K., Hon G., et al. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet 2007, 39:311-318.
27. Tuupanen S., Niittymaki I., Nousiainen K., et al. Allelic imbalance at rs6983267 suggests selection of the risk allele in somatic colorectal tumor evolution. Cancer Res 2008, 68:14-17.
28. Saleque S., Cameron S., Orkin S.H. The zinc-finger proto-oncogene Gfi-1b is essential for development of the erythroid and megakaryocytic lineages. Genes Dev 2002, 16:301-306.
29. Person R.E., Li F.Q., Duan Z., et al. Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2. Nat Genet 2003, 34:308-312.
30. Karsunky H., Zeng H., Schmidt T., et al. Inflammatory reactions and severe neutropenia in mice lacking the transcriptional repressor Gfi1. Nat Genet 2002, 30:295-300.
31. Elmaagacli A.H., Koldehoff M., Zakrzewski J.L., et al. Growth factor-independent 1B gene (GFI1B) is overexpressed in erythropoietic and megakaryocytic malignancies and increases their proliferation rate. Br J Haematol 2007, 136:212-219.
32. Wallis D., Hamblen M., Zhou Y., et al. The zinc finger transcription factor Gfi1, implicated in lymphomagenesis, is required for inner ear hair cell differentiation and survival. Development 2003, 130:221-232.
33. Shroyer N.F., Wallis D., Venken K.J., et al. Gfi1 functions downstream of Math1 to control intestinal secretory cell subtype allocation and differentiation. Genes Dev 2005, 19:2412-2417.
34. Kazanjian A., Wallis D., Au N., et al. Growth factor independence-1 is expressed in primary human neuroendocrine lung carcinomas and mediates the differentiation of murine pulmonary neuroendocrine cells. Cancer Res 2004, 64:6874-6882.
35. Duan Z., Horwitz M. Targets of the transcriptional repressor oncoprotein Gfi-1. Proc Natl Acad Sci U S A 2003, 100:5932-5937.
36. Laurent B., Randrianarison-Huetz V., Kadri Z., et al. Gfi-1B promoter remains associated with active chromatin marks throughout erythroid differentiation of human primary progenitor cells. Stem Cells 2009, 27:2153-2162.
37. He J., Wilkens L.R., Stram D.O., et al. Generalizability and epidemiologic characterization of eleven colorectal cancer GWAS hits in multiple populations. Cancer Epidemiol Biomarkers Prev 2011, 20:70-81.
38. Kupfer SS, Anderson JR, Hooker S, et al. Genetic heterogeneity in colorectal cancer associations between African and European Americans. Gastroenterology;139:1677-1685, 1685.e1-8.